Academic Journal

PROGNOSIS-RELATED NOVEL IMMUNOSTAINING PATTERN FOR PROGRAMMED CELL DEATH LIGAND 1 AND PROGNOSTIC VALUE OF TUMOUR-INFILTRATING LYMPHOCYTES IN TRIPLE-NEGATIVE BREAST CANCER.

التفاصيل البيبلوغرافية
العنوان: PROGNOSIS-RELATED NOVEL IMMUNOSTAINING PATTERN FOR PROGRAMMED CELL DEATH LIGAND 1 AND PROGNOSTIC VALUE OF TUMOUR-INFILTRATING LYMPHOCYTES IN TRIPLE-NEGATIVE BREAST CANCER.
المؤلفون: SAVAŞ, PINAR, SERIN, GÜRDENIZ, GÜRSOY, PINAR, ZEKIOĞLU, OSMAN, ÖZDEMIR, NECMETTIN
المصدر: Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists; 2023, Vol. 74 Issue 2, p65-74, 10p
مستخلص: This study aims to determine the prognostic significance of programmed cell death ligand 1 (PD-L1) expression and tumour-infiltrating lymphocytes (TILs) in triple-negative breast cancer (TNBC). PD-L1 expression and TIL percentage were determined in TNBCs that did not receive neoadjuvant therapy. The relationship between PD-L1 expression and the percentage of TILs with survival was investigated. The presence of intratumoural PD-L1-positive tumour-infiltrating immune cells (TIICs) in tumours with ≥ 1% PD-L1 expression was identified as a new PD-L1 evaluation parameter. The presence of intratumoural PD-L1-positive TIICs as a new parameter in PD-L1-positive cases increased overall survival. The percentage of TILs increased in both overall and distant metastasis-free survival (p = 0.040 and p = 0.006, respectively). As a result, it was found that the risk of death was increased 5.18-fold (p = 0.013) in patients without intratumoural PD-L1-positive TIICs. This risk of death was calculated to be 5.40-fold higher in patients with TIL percentage ≤ 10% than in those with > 40% (p = 0.024), and the risk of distant metastasis was calculated to be 11.95 times higher. In our study, we discovered that the percentage of TILs made a statistically significant difference in TNBC survival. The presence of intratumoural PD-L1-positive TIICs in PD-L1-positive cases significantly increased survival. [ABSTRACT FROM AUTHOR]
Copyright of Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists is the property of Termedia Publishing House and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:12339687
DOI:10.5114/pjp.2023.129014